Literature DB >> 18192472

CT-guided core needle biopsy in the diagnosis of pancreatic diseases with an automated biopsy gun.

Li Li1, Li-Zhi Liu, Qiu-Liang Wu, Yun-Xian Mo, Xue-Wen Liu, Chun-Yan Cui, De-Sen Wan.   

Abstract

PURPOSE: To evaluate the safety and diagnostic accuracy of computed tomographic (CT)-guided core needle biopsy (CNB) in the diagnosis of pancreatic diseases by using an automated biopsy gun with a cutting-type needle.
MATERIALS AND METHODS: From January 2000 to January 2006, CT-guided CNB was performed in 80 patients suspected of having pancreatic diseases in the absence of liver metastasis. Biopsies were performed with an 18-20-gauge cutting needle driven by a spring-loaded biopsy gun. Histologic reports and medical records of all patients were retrospectively reviewed. An institutional review board exemption was obtained to perform this retrospective study.
RESULTS: All patients tolerated the biopsies well, with no serious complications. Three patients had mild abdominal pain after the procedure, and a limited abdominal CT scan did not reveal any marked abnormality. Two patients had an elevated serum amylase level, which returned to normal within 2 weeks. A definitive diagnosis and accurate histologic diagnosis were obtained for 69 patients, for a successful diagnosis rate of 86%. Surgical sampling was performed in 11 patients with neoplasms and nondiagnostic core-needle biopsies. Only 50% of patients with well-differentiated adenocarcinomas were definitely diagnosed with CT-guided CNB.
CONCLUSIONS: CT-guided CNB with an automated biopsy gun is a safe and effective method for obtaining tissue for the histologic evaluation of pancreatic diseases. However, CT-guided CNB requires further development for the accurate diagnosis of well-differentiated adenocarcinomas.

Entities:  

Mesh:

Year:  2008        PMID: 18192472     DOI: 10.1016/j.jvir.2007.09.001

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  5 in total

Review 1.  The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.

Authors:  Anteneh A Tesfaye; Mandana Kamgar; Asfar Azmi; Philip A Philip
Journal:  Expert Rev Anticancer Ther       Date:  2017-12-19       Impact factor: 4.512

2.  Percutaneous transgastric computed tomography-guided biopsy of the pancreas using large needles.

Authors:  Hsiuo-Shan Tseng; Chia-Yuen Chen; Wing-P Chan; Jen-Huey Chiang
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

3.  Is laparoscopic management suitable for solid pseudo-papillary tumors of the pancreas?

Authors:  P O Fais; E Carricaburu; S Sarnacki; D Berrebi; D Orbach; V Baudoin; Pascal de Lagausie
Journal:  Pediatr Surg Int       Date:  2009-05-29       Impact factor: 1.827

4.  A CT-guided fat transversing coaxial biopsy technique for pancreatic lesion biopsy that avoids major organs and vessels.

Authors:  Chia-Ying Lin; Ming-Ching Ou; Yi-Sheng Liu; Ming-Tsung Chuang; Yan-Shen Shan; Hong-Ming Tsai; Chien-Kuo Wang; Yi-Shan Tsai
Journal:  Saudi J Gastroenterol       Date:  2017 Nov-Dec       Impact factor: 2.485

5.  Ultrasound-Guided Percutaneous Core Needle Biopsy of Abdominal Viscera: Tips to Ensure Safe and Effective Biopsy.

Authors:  Jin Woong Kim; Sang Soo Shin
Journal:  Korean J Radiol       Date:  2017-02-07       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.